Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: Implications for vaccine development

被引:219
|
作者
Pierson, Theodore C. [1 ]
Fremont, Daved H. [2 ,3 ]
Kuhn, Richard J. [6 ]
Diamond, Michael S. [2 ,3 ,4 ,5 ]
机构
[1] NIH, Viral Pathogenesis Sect, Viral Dis Lab, Bethesda, MD 20892 USA
[2] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[6] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA
关键词
D O I
10.1016/j.chom.2008.08.004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Flaviviruses are a group of small RNA viruses that cause severe disease in humans worldwide and are the target of several vaccine development programs. A primary goal of these efforts is to elicit a protective humoral response directed against the envelope proteins arrayed on the surface of the flavivirus virion. Advances in the structural biology of these viruses has catalyzed rapid progress toward understanding the complexity of the flavivirus immunogen and the molecular basis of antibody-mediated neutralization. These insights have identified factors that govern the potency of neutralizing antibodies and will inform the design and evaluation of novel vaccines.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 50 条
  • [41] In vivo Mechanisms of Antibody-Mediated Neurological Disorders: Animal Models and Potential Implications
    Giannoccaro, Maria Pia
    Wright, Sukhvir K.
    Vincent, Angela
    FRONTIERS IN NEUROLOGY, 2020, 10
  • [42] Antibody-Mediated Neutralization of Perfringolysin 0 for Intracellular Protein Delivery
    Yang, Nicole J.
    Liu, David V.
    Sklaviadis, Demetra
    Gui, Dan Y.
    Vander Heiden, Matthew G.
    Wittrup, K. Dane
    MOLECULAR PHARMACEUTICS, 2015, 12 (06) : 1992 - 2000
  • [43] A requirement for FcγR in antibody-mediated bacterial toxin neutralization
    Abboud, Nareen
    Chow, Siu-Kei
    Saylor, Carolyn
    Janda, Alena
    Ravetch, Jeffery V.
    Scharff, Matthew D.
    Casadevall, Arturo
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (11): : 2395 - 2405
  • [44] The molecular basis of antibody-mediated neutralization of West Nile virus
    Oliphant, Theodore
    Diamond, Michael S.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (06) : 885 - 892
  • [45] Mechanisms of organ transplant injury mediated by B cells and antibodies: Implications for antibody-mediated rejection
    Chong, Anita S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 23 - 32
  • [46] Antigenic diversity of Plasmodium falciparum and antibody-mediated parasite neutralization
    Bolad, A
    Berzins, K
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2000, 52 (03) : 233 - 239
  • [47] Recent insights into antiphospholipid antibody-mediated thrombosis
    Field, SL
    Brighton, TA
    McNeil, HP
    Chesterman, CN
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 1999, 12 (03) : 407 - 422
  • [48] Advances in antibody-mediated immunity against Mycobacterium tuberculosis:: implications for a novel vaccine strategy
    Glatman-Freedman, A
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2003, 39 (01): : 9 - 16
  • [49] In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16
    White, WI
    Wilson, SD
    Bonnez, W
    Rose, RC
    Koenig, S
    Suzich, JA
    JOURNAL OF VIROLOGY, 1998, 72 (02) : 959 - 964
  • [50] The involvement of FcR mechanisms in antibody-mediated rejection
    Lee, Chih-Yuan
    Lotfi-Emran, Sahar
    Erdinc, Melek
    Murata, Kazunori
    Velidedeoglu, Ergun
    Fox-Talbot, Karen
    Liu, Jinhuan
    Garyu, Justin
    Baldwin, William M., III
    Wasowska, Barbara A.
    TRANSPLANTATION, 2007, 84 (10) : 1324 - 1334